GLP-1 drugs linked to dramatically lower death rates in colon cancer patients

Published Date: 12 Nov 2025

A new University of California San Diego study offers compelling evidence that glucagon-like peptide-1 (GLP-1) receptor agonists—the class of drugs behind Ozempic, Wegovy and Mounjaro, for example—may do more than regulate ...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Chronic pain and poor sleep are troublesome bed partners.

2.

Let's Talk Breast Density; Cancer, Movies, and Music; Treatment-Induced Aging?

3.

Invest in generics as a lesson from the shortages of chemotherapy.

4.

GLP-1 drugs linked to dramatically lower death rates in colon cancer patients

5.

The main subject is associated with suicide in the United States.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot